医思健康(02138)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02138 医思健康

已收盘 09-25 16:00:00

0.560

-0.010

-1.75%

最高0.570	最低0.535	成交量74.10万
今开0.570	昨收0.570	日振幅6.14%
总市值6.64亿	流通市值6.64亿	总股本11.85亿
成交额41.73万	换手率0.06%	流通股本11.85亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02138","market":"HK","secType":"STK","nameCN":"医思健康","latestPrice":0.56,"timestamp":1790323200007,"preClose":0.57,"halted":0,"volume":741000,"delay":0,"changeRate":-0.01754385964912263,"floatShares":1185000000,"shares":1185000000,"eps":-0.34,"marketStatus":"已收盘","change":-0.01,"latestTime":"09-25 16:00:00","open":0.57,"high":0.57,"low":0.535,"amount":417335,"amplitude":0.061404,"askPrice":0.575,"askSize":10000,"bidPrice":0.57,"bidSize":38000,"shortable":0,"etf":0,"ttmEps":-0.34,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790559000000},"marketStatusCode":5,"adr":0,"listingDate":1457625600000,"exchange":"SEHK","adjPreClose":0.57,"openAndCloseTimeList":[[1790299800000,1790308800000],[1790312400000,1790323200000]],"volumeRatio":2.571113,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02138","defaultTab":"news","newsList":[{"id":"1171762565","title":"医思健康：李向荣增持，好仓比例升至0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171762565","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171762565?lang=zh_cn&edition=full","pubTime":"2026-09-25 17:24","pubTimestamp":1790328244,"startTime":"0","endTime":"0","summary":"根据披露，李向荣于2026年9月23日在联交所场内以每股均价0.5387港元买入医思健康26.80万股，涉资约14.44万港元，属场内主动交易，即在二级市场直接买卖股份。李向荣此次增持前持有医思健康好仓827.05万股，占比0.70%；增持后持股量为853.85万股，好仓比例升至0.72%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136501564","title":"医思健康：李向荣增持，好仓比例升至0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136501564","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136501564?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:42","pubTimestamp":1790156574,"startTime":"0","endTime":"0","summary":"李向荣于2026年9月22日在联交所场内以每股均价0.5182港元买入医思健康股份13.90万股，涉资约7.20万港元，属场内主动交易，即在二级市场直接买卖股份。李向荣此次增持前持有医思健康好仓813.15万股，占比0.69%；增持后持股量为827.05万股，好仓比例升至0.7%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131580381","title":"医思健康：邓志辉增持，好仓比例升至61.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131580381","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131580381?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:50","pubTimestamp":1789984249,"startTime":"0","endTime":"0","summary":"邓志辉于2026年9月16日在联交所场内以每股均价0.5港元买入医思健康33.50万股，涉资约16.75万港元，属场内主动交易，即在二级市场直接买卖股份。邓志辉此次增持前持有医思健康好仓7.24亿股，占比61.07%；增持后持股量为7.24亿股，好仓比例升至61.1%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137647136","title":"医思健康：李向荣增持，好仓比例升至0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137647136","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137647136?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:22","pubTimestamp":1789723372,"startTime":"0","endTime":"0","summary":"李向荣于2026年9月16日在联交所场内以每股均价0.5025港元买入医思健康股份20.00万股，涉资约10.05万港元。属场内主动交易，即在二级市场直接买卖股份。李向荣此次增持前持有医思健康好仓783.75万股，占比0.66%；增持后持股量为803.75万股，好仓比例升至0.68%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157431502","title":"医思健康：李向荣增持，好仓比例升至0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157431502","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157431502?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:14","pubTimestamp":1789722898,"startTime":"0","endTime":"0","summary":"李向荣于2026年9月17日在联交所场内以每股均价0.5150港元买入医思健康9.40万股，涉资约4.84万港元，属场内主动交易，即在二级市场直接买卖股份。李向荣此次增持前持有医思健康好仓803.75万股，占比0.68%；增持后持股量为813.15万股，好仓比例升至0.69%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667352981","title":"医思健康(02138.HK)获执行董事李向荣增持20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667352981","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667352981?lang=zh_cn&edition=full","pubTime":"2026-09-16 22:17","pubTimestamp":1789568222,"startTime":"0","endTime":"0","summary":"格隆汇9月16日丨根据联交所最新权益披露资料显示，2026年9月15日，医思健康(02138.HK)获执行董事李向荣在场内以每股均价0.505港元增持20万股，涉资约10.1万港元。\n\n　　增持后，李向荣最新持股数目为783.75万股，持股比例由0.64%上升至0.66%。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/16/20260916996987.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/16/20260916996987.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260916/32372254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02138","BK1511","BK1215","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187315919","title":"医思健康：李向荣增持，好仓比例升至0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187315919","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187315919?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:33","pubTimestamp":1789551189,"startTime":"0","endTime":"0","summary":"李向荣于2026年9月15日在联交所场内以每股均价0.505港元买入医思健康20.00万股，涉资约10.10万港元，属场内主动交易，即在二级市场直接买卖股份。李向荣此次增持前持有医思健康好仓763.75万股，占比0.64%；增持后持股量为783.75万股，好仓比例升至0.66%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196695650","title":"医思健康：李向荣增持，好仓比例升至0.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196695650","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196695650?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:31","pubTimestamp":1789551085,"startTime":"0","endTime":"0","summary":"李向荣于2026年9月14日在联交所场内以每股均价0.5096港元买入医思健康70.00万股，涉资约35.67万港元，属场内主动交易，即在二级市场直接买卖股份。李向荣此次增持前持有医思健康好仓693.75万股，占比0.59%；增持后持股量为763.75万股，好仓比例升至0.64%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199720455","title":"医思健康：邓志辉增持，好仓比例升至61.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199720455","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199720455?lang=zh_cn&edition=full","pubTime":"2026-09-15 17:33","pubTimestamp":1789464804,"startTime":"0","endTime":"0","summary":"邓志辉于2026年9月11日以每股均价0.4994港元买入医思健康（02138）157.10万股，涉资约78.46万港元。邓志辉此次增持前持有医思健康好仓7.22亿股，占比60.93%；增持后持股量为7.24亿股，好仓比例升至61.07%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175281349","title":"医思健康：邱明利增持，好仓比例升至61.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=1175281349","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175281349?lang=zh_cn&edition=full","pubTime":"2026-09-15 17:31","pubTimestamp":1789464665,"startTime":"0","endTime":"0","summary":"邱明利于2026年9月11日以每股均价0.4994港元买入医思健康（02138）股份157.10万股，涉资约78.46万港元。邱明利此次增持前持有医思健康好仓7.22亿股，占比60.93%；增持后持股量为7.24亿股，好仓比例升至61.07%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127098335","title":"医思健康更新2026年8月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1127098335","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127098335?lang=zh_cn&edition=full","pubTime":"2026-09-01 15:35","pubTimestamp":1788248149,"startTime":"0","endTime":"0","summary":"医思健康于2026年9月1日发布截至2026年8月31日的证券变动月报表。公告显示，公司法定/注册股本维持在38,000,000,000股普通股，总面值为每股面值0.00001港元，合计380,000港元，与上月保持不变。公司已发行普通股合计1,185,211,265股，与上月持平。报告期内未有新增发行、购回、注销或将股份列为库藏股的记录。截至2026年8月31日，库藏股数目仍为0股。公司表示，已符合主板上市规则相关公众持股量要求，并确认已遵守香港联交所《上市规则》及其他适用法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137505680","title":"医思健康（02138）股东周年大会所有议案获高票通过 逾六成股东参会","url":"https://stock-news.laohu8.com/highlight/detail?id=1137505680","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137505680?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:40","pubTimestamp":1787305237,"startTime":"0","endTime":"0","summary":"2026年8月21日，医思健康在股东周年大会上就全部6项普通决议进行投票表决。公告显示，公司已发行股份总数为1,185,211,265股。持有720,305,602股股份、占已发行股份总数60.77%的股东出席了本次会议。由于所有普通决议案均获得超过50%的赞成票，全部议案正式获通过。出席本次股东周年大会的董事包括邓志辉、吕联炜、李向荣、陆韵晟、梁杨世嫡、马清楠及陆东，区俊因工作原因未能出席。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164655835","title":"医思健康2026年7月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1164655835","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164655835?lang=zh_cn&edition=full","pubTime":"2026-08-06 10:02","pubTimestamp":1785981747,"startTime":"0","endTime":"0","summary":"2026年8月6日，医思健康发布2026年7月证券变动月报表，报告期截至2026年7月31日。在购股权方面，截至7月底，根据2016年2月19日股东大会通过的购股权计划，18,922,500份购股权仍未行使，本月未有新增发行或自库存转让股份，亦无行使购股权所带来的资金流入。另有一项购股权计划标示期初余量为59,260,563份，但本月结存调整为0份，未导致公司已发行股份或库藏股份发生变化。截至报告期末，公司股本总数保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655877867","title":"医思健康：截至2026年3月31日止财年净亏损4.03亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2655877867","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655877867?lang=zh_cn&edition=full","pubTime":"2026-07-30 19:02","pubTimestamp":1785409320,"startTime":"0","endTime":"0","summary":"每经AI快讯，7月30日，医思健康（02138.HK）公告：截至二零二六年三月三十一日止财年，公司总收入为37.70亿港元；年内本公司权益股东应占亏损为4.03亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-30/doc-inikquqi1866813.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-30/doc-inikquqi1866813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1511","02138","BK1593","BK1215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120620312","title":"医思健康（02138）2025/26财年业绩承压 收入下降9%且由盈转亏至4.13亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120620312","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120620312?lang=zh_cn&edition=full","pubTime":"2026-07-30 18:55","pubTimestamp":1785408948,"startTime":"0","endTime":"0","summary":"医思健康公布截至2026年3月31日止2025/26财年业绩，录得收入37.70亿港元，较2024/25财年的41.40亿港元下降9.0%。调整后息税折旧摊销前盈利为2.80亿港元，同比减少25.3%，调整后息税折旧摊销前盈利率亦由上一年9.2%降至6.6%。年内净利润率由负4.0%进一步恶化至负11.0%，全年净亏损合计4.13亿港元，上年同期亏损为1.12亿港元，整体经营表现明显承压。受此影响，归属于本公司股东的亏损亦扩大至4.03亿港元，每股基本亏损增加至34.0港仙；董事会建议不派发股息。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"医思健康（02138）2025/26财年业绩承压 收入下降9%且由盈转亏至4.13亿港元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120287548","title":"医思健康(02138)授予董事股份购回授权 规模达已发行股本10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120287548","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120287548?lang=zh_cn&edition=full","pubTime":"2026-07-30 18:51","pubTimestamp":1785408695,"startTime":"0","endTime":"0","summary":"医思健康在其最新公告中披露，董事会将于2026年8月21日的股东周年大会上寻求授权，可回购不超过公司已发行股本10%的股份。根据2026年7月23日的已发行股份总数1,185,211,265股，回购上限为118,521,126股。若董事会在有关期间行使回购授权，回购股份的数量将受上述上限限制，且相应遵守相关法规要求。公司同时提醒股东，本次股份购回授权及其他相关议案将于2026年8月21日举行的股东周年大会上审议，股东登记将于2026年8月18日至8月21日暂时关闭。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"医思健康(02138)授予董事股份购回授权 规模达已发行股本10%","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108425325","title":"医思健康（02138）公布召开2026年股东周年大会 将审议董事改选及20%增发、10%回购授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1108425325","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108425325?lang=zh_cn&edition=full","pubTime":"2026-07-30 18:51","pubTimestamp":1785408675,"startTime":"0","endTime":"0","summary":"医思健康7月30日发布股东周年大会通告，公司将于2026年8月21日（星期五）上午10时30分在香港鰂鱼涌英皇道979号太古坊富卫中心20楼举行股东周年大会，审议及表决多项普通决议案。若于2026年8月21日上午8时正，黑色暴雨警告信号或八号或以上热带气旋警告信号仍然生效，股东周年大会将顺延。公司将通过官网另行公告会议安排。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651289171","title":"【券商聚焦】中信证券：预计美妆行业在次季延续低速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2651289171","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651289171?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:55","pubTimestamp":1783990545,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研究指，22026Q2，预计美妆行业在需求疲弱、流量成本走高、内容运营压力加大的背景下延续低速增长；结构性进一步分化，国际高端品牌销售反弹，本土大众、中端定位品牌承压；毛戈平、林清轩延续高增长，巨子生物、贝泰妮、敷尔佳销售底部回升。2026Q2，医美板块上游产品供给增加，竞争延续较高强度，四环医药受益于自主产品上市继续提升市场份额。估值已充分反映当前的经营压力且已严重低估，静候基本面改善和估值回升。","market":"other","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985765","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2495084118.USD","LU1720050803.USD","LU1794554557.SGD","HK0000165453.HKD","BK0276","LU1997244956.HKD","02196","BK1585","LU0405327494.USD","BK0012","LU1997245177.USD","BK1511","BK1515","02373","06030","BK0028","BK0188","LU1328615791.USD","BK1587","KCE","LU2289578879.USD","BK1207","02367","01696","BK1600","LU1655091616.SGD","LU2488822045.USD","BK0196","BK1147","01530","BK1100","06699","BK1521","LU0405327148.USD","SG9999004311.SGD","00460","LU1580142542.USD","LU1997245094.SGD","BK1564","BK1583","LU2148510915.USD","BK1215","LU1255011170.USD","02138","BK0183","600030","BK1161","LU1064130708.USD","BK1516","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122857819","title":"医思健康更新6月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1122857819","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122857819?lang=zh_cn&edition=full","pubTime":"2026-07-06 11:06","pubTimestamp":1783307199,"startTime":"0","endTime":"0","summary":"医思健康于2026年7月6日发布截至2026年6月30日止的证券变动月报表。公告显示，公司在本报告期内总股本及已发行股份数量均无变化，股本保持稳定。已发行股份总数为1,185,211,265股，相比上月底无增减，库存股份数量保持为0股，未发生新的股份发行、股份购回或注销事宜。在股权激励方面，公司基于2016年2月19日股东大会审批的奖励计划，已授出18,922,500份购股权，另一项经2023年5月29日股东大会审批的购股权计划则合计授出59,260,563份购股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02138"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647376944","title":"医思健康：二零二六年净亏损4.03亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647376944","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647376944?lang=zh_cn&edition=full","pubTime":"2026-06-29 19:13","pubTimestamp":1782731580,"startTime":"0","endTime":"0","summary":"南财智讯6月29日电，医思健康（02138.HK）公告，截至二零二六年三月三十一日止年度，公司总收入为37.70亿港元，同比下降8.9%；本公司权益股东应占亏损为4.03亿港元；每股基本亏损为0.34港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606293786840426.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606293786840426.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1215","02138","BK1511","BK1593"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://Hang Seng Bank","stockEarnings":[{"period":"1week","weight":0.0962},{"period":"1month","weight":0.3735},{"period":"3month","weight":0.5616},{"period":"6month","weight":0.1753},{"period":"1year","weight":-0.2597},{"period":"ytd","weight":-0.0339}],"compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":-0.0294},{"period":"3month","weight":0.0922},{"period":"6month","weight":-0.0076},{"period":"1year","weight":-0.0663},{"period":"ytd","weight":-0.0339}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"医思健康是一家主要从事提供医疗及保健服务的投资控股公司。该公司主要通过三个业务分部进行运营。医疗服务分部提供医疗服务及牙科服务等。美学医疗、美容及养生服务分部提供美学医疗、传统美容、护发及辅助养生服务以及销售护肤、保健及美容产品。其他分部提供营销及相关服务以及兽医服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.024607},{"month":2,"riseRate":0.4,"avgChangeRate":0.028343},{"month":3,"riseRate":0.2,"avgChangeRate":-0.085028},{"month":4,"riseRate":0.363636,"avgChangeRate":0.022432},{"month":5,"riseRate":0.363636,"avgChangeRate":0.057187},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.031519},{"month":7,"riseRate":0.545455,"avgChangeRate":-0.003974},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.006176},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.005187},{"month":10,"riseRate":0.4,"avgChangeRate":-0.036873},{"month":11,"riseRate":0.5,"avgChangeRate":0.064266},{"month":12,"riseRate":0.4,"avgChangeRate":0.037118}],"exchange":"SEHK","name":"医思健康","nameEN":"EC HEALTHCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医思健康(02138)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医思健康(02138)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医思健康,02138,医思健康股票,医思健康股票老虎,医思健康股票老虎国际,医思健康行情,医思健康股票行情,医思健康股价,医思健康股市,医思健康股票价格,医思健康股票交易,医思健康股票购买,医思健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医思健康(02138)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医思健康(02138)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}